Liposinol is a unique and patented lipophilic fibre from dehydrated leaves of cactus, Opuntia ficus-indica. Liposinol™ has been clinically proven to be effective in reducing dietary fat absorption, subsequently reducing the calories absorbed from fat.
There are a few pre-clinical and clinical studies conducted at the TNO Nutrition and Food Research, The Netherlands and CERN (Centre d’Enseignement et de Recherche en Nutrition) in France.
The results from these studies have consistently shown that Liposinol™ binds 28% of dietary fat and have proven its efficacy as a fat binder. |
|
In a recent clinical study on Metabolic Syndrome, Liposinol™ has once again proven its fat binding capacity resulting in a significant reduction of LDL-cholesterol. This study was published last year in a peer-reviewed journal, Advances in Therapy.
These promising results have shown us new angles in which to direct our research on Liposinol™. This on-going process continues as we further explore the diversified functions of Liposinol™ as a weight management tool. |
